In a 72-year-old hospitalized patient with community-acquired pneumonia receiving antibiotics who develops diarrhea, which factor does NOT increase the risk of Clostridioides difficile infection: frailty with comorbidities, age <50 years, immunosuppression/chemotherapy, history of idiopathic inflammatory bowel disease, or proton pump inhibitor use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Age <50 Years Does NOT Increase Risk of Clostridioides difficile Infection

The correct answer is B) Age <50 years - this is the only factor listed that does NOT increase CDI risk; in fact, younger age is protective, as advanced age is one of the most important risk factors for CDI.

Risk Factor Analysis Based on IDSA/SHEA Guidelines

According to the authoritative 2018 IDSA/SHEA guidelines 111, the established risk factors for CDI include:

Confirmed Risk Factors (Options A, C, D, E):

  • Advanced age is explicitly identified as "one of the most important risk factors for CDI" 11. The guidelines note that older age increases risk for both initial CDI and complicated disease with higher mortality 11.

  • Frailty with comorbidities (Option A): The guidelines specifically state that "risk factors for complicated disease include older age, leukocytosis, renal failure and comorbidities" 11. Comorbidities are consistently associated with increased CDI risk and mortality.

  • Immunosuppression/chemotherapy (Option C): The guidelines clearly state that "cancer chemotherapy is another risk factor for CDI" mediated by antibiotic activity and immunosuppressive effects of neutropenia 11. HIV-infected patients are at "specific increased risk because of their underlying immunosuppression" 1.

  • Inflammatory bowel disease (Option D): IBD is explicitly listed as a risk factor, with the guidelines noting that "low vitamin D levels being an independent risk factor among...those with underlying inflammatory bowel disease" 1. The 2020 Taiwan guidelines 22 also confirm IBD as a risk factor.

  • Proton pump inhibitors (Option E): While controversial, PPIs are discussed extensively as a potential risk factor. The guidelines note "a number of studies have suggested an epidemiologic association between use of stomach acid–suppressing medications, primarily PPIs, and CDI" 111. One study showed "continuous use of PPIs was independently associated with a 50% increased risk for recurrence" 11.

The Protective Factor (Option B):

Age <50 years is protective - the inverse relationship is what matters here. The guidelines consistently emphasize that advanced age increases risk, meaning younger age (<50 years) does NOT increase risk and actually provides relative protection 111.

Clinical Context for This Patient

Your 72-year-old patient has multiple CDI risk factors:

  • Advanced age (72 years) - major risk factor
  • Antibiotic exposure (ampicillin prior to admission, current antibiotics for pneumonia) - the most important modifiable risk factor 11
  • Hospitalization - duration increases exposure risk 1
  • Potential PPI use (common in hospitalized patients) - controversial but possible contributor

Key Clinical Pitfall

Don't be confused by the question format asking what does NOT increase risk. Age <50 is the outlier because it represents the absence of a risk factor (advanced age), making it the correct answer.

Related Questions

Is famotidine likely to cause Clostridioides difficile infection?
Is the risk of Clostridioides difficile infection associated with famotidine use dose‑dependent?
Does omeprazole increase the risk of Clostridioides difficile infection?
What non‑proton‑pump inhibitor treatment options are appropriate for a patient with dyspeptic symptoms who wants to avoid PPIs due to a remote history of Clostridioides difficile infection?
What alternative acid‑suppression therapy can be used for a patient who refuses proton pump inhibitors due to risk of Clostridioides difficile infection and QT prolongation?
In a hemodynamically stable patient with a catheter‑associated bloodstream infection caused by ESBL‑producing Proteus mirabilis, is ertapenem 1 g IV daily appropriate as definitive therapy, and what are the recommended duration and monitoring steps?
What are the possible causes of an elevated C-reactive protein (CRP) of 15 mg/L in a kidney transplant recipient?
For a 25‑year‑old patient with chronic constipation and abdominal pain that occurs with every meal, should the linaclotide dose be increased to 290 µg?
In which valvular heart diseases is anticoagulation indicated, and which anticoagulant should be used?
In a 75-year-old man with a history of colon cancer presenting with bacterial meningitis (elevated opening pressure, CSF pleocytosis with neutrophil predominance, low CSF-to-blood glucose ratio, and elevated protein), what empiric antimicrobial regimen should be selected?
What is the recommended warfarin initiation dose and target INR for a patient with a mechanical aortic valve?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.